MEI Pharma Inc (MEIP)
2.90
-0.11
(-3.65%)
USD |
NASDAQ |
Nov 15, 10:40
MEI Pharma Free Cash Flow (Quarterly): -18.00M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.00M |
| March 31, 2024 | -2.928M |
| December 31, 2023 | -11.06M |
| September 30, 2023 | -18.49M |
| June 30, 2023 | -11.34M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -14.21M |
| September 30, 2022 | -14.84M |
| June 30, 2022 | -15.81M |
| March 31, 2022 | -17.07M |
| December 31, 2021 | -8.617M |
| September 30, 2021 | -7.729M |
| June 30, 2021 | -11.26M |
| March 31, 2021 | -15.65M |
| December 31, 2020 | 3.994M |
| September 30, 2020 | -9.755M |
| June 30, 2020 | 69.00M |
| March 31, 2020 | -11.08M |
| December 31, 2019 | -10.49M |
| September 30, 2019 | -14.08M |
| June 30, 2019 | -8.074M |
| March 31, 2019 | -11.38M |
| December 31, 2018 | 2.627M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | -3.483M |
| Date | Value |
|---|---|
| March 31, 2018 | -6.239M |
| December 31, 2017 | -4.751M |
| September 30, 2017 | -6.562M |
| June 30, 2017 | -3.195M |
| March 31, 2017 | 1.606M |
| December 31, 2016 | -3.747M |
| September 30, 2016 | 8.771M |
| June 30, 2016 | -3.484M |
| March 31, 2016 | -4.388M |
| December 31, 2015 | -4.228M |
| September 30, 2015 | -5.761M |
| June 30, 2015 | -6.741M |
| March 31, 2015 | -8.154M |
| December 31, 2014 | -6.458M |
| September 30, 2014 | -6.731M |
| June 30, 2014 | -5.879M |
| March 31, 2014 | -5.087M |
| December 31, 2013 | -4.466M |
| September 30, 2013 | -4.069M |
| June 30, 2013 | -2.776M |
| March 31, 2013 | -2.655M |
| December 31, 2012 | -2.162M |
| September 30, 2012 | -2.489M |
| June 30, 2012 | -1.304M |
| March 31, 2012 | -2.273M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-18.49M
Minimum
Sep 2023
69.00M
Maximum
Jun 2020
-7.234M
Average
-11.26M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Avid Bioservices Inc | -4.991M |
| Evoke Pharma Inc | -0.8187M |
| Revance Therapeutics Inc | -41.15M |
| NovaBay Pharmaceuticals Inc | -2.063M |
| Palatin Technologies Inc | -6.477M |